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The relationship has been studied  (1)  between the stimulation by antigen of the 
rate of deoxyribonucleic  acid (DNA) synthesis and cell division, and the production of 
specific hemolytic antibody-synthesizing cells in suspensions  of cells from the  spleens 
of rabbits undergoing  a  secondary response to  sheep red blood cells  (SRC's). The 
results,  using the specific hemolytic plaque technique, indicated that the majority of 
antibody-producing cells arose from the DNA-synthesizing population but that only 
a small proportion of all these cells, dividing  in vitro in response to specific antigen, 
actually produced antibody to SRC's under the conditions  of the experiments. The 
present paper reports the effects  of actinomycin D  and puromycin on such cells in 
vitro. 
The mode of action of actinomycin D  has been well established (2, 3). This anti- 
biotic has been shown  to block ribonucleic  acid (RNA)  synthesis by binding to the 
deoxyguanosine  residues  of DNA in a  selective manner, with resulting interference 
with  the  formation of RNA polymerase as  the primary effect.  Suppression  of the 
incorporation of uridine and cytidine into nucleolar RNA has been shown  (4)  to be 
the earliest effect of low concentrations of this inhibitor on mammalian ceils in tissue 
culture. More recent reports (5) have suggested that there may be other effects of this 
agent on cells, such as glucose deprivation, resulting in reduced protein synthesis. 
Antibody synthesis in vitro is inhibited by actiuomycin D  (6-8) but its effect on 
antibody responses  in intact animals has been found to be more variable. This anti- 
biotic partially inhibited the primary response to SRC's in mice (9), while  another 
study (10), using actinomycin C, failed to suppress the antibody response of rabbit 
spleen  cells  transferred into newborn rabbits.  In another report  (11),  actinomycin 
D  delayed the appearance of antibody in  the  serum of rats undergoing a  primary 
response,  but there was no apparent effect on total circulating antibody production, 
while persistence of secondary antibody production in the presence of toxic doses of 
this inhibitor in mice has been described  (12). An interesting study (13) has reported 
the conversion  of the tolerogenic  stimulus of soluble  bovine gamma globulin  into an 
immunogenic one by actinomycin D. Investigations of other types of protein synthesis 
in  intact animals have shown  that actinomycin D  could  induce  the production of 
adaptive enzymes in rat liver (14) while both actinomycin D and puromycin accelerated 
the increase  of alkaline phosphatase activity in  the duodenum of young mice (15). 
675 676  ANTIBODY  PRODUCTION  IN  VITRO.  II 
In vitro studies using actinomycin D  have shown both inhibition (16)  as  well  as 
stimulation (17) of protein synthesis in cells of mammalian origin. 
Puromycin inhibits protein synthesis in cell-free systems (18) as well as whole cells 
(19),  and differences  between its mode of action in vivo and in vitro have been re- 
ported (20). Studies of the structural requirements for its inhibitory effects on protein 
synthesis (21)  have suggested that this antibiotic binds to the active center of an 
enzyme or RNA protein involved in the final steps of protein synthesis. Antibody 
synthesis by rabbit lymph node cells  (6)  and mouse spleen cells  (22)  in vitro was 
inhibited by puromycin in the same way as were other types of protein synthesis. 
Materials and Methods 
Immunization  of rabbits, preparation and culture of spleen cell suspensions, estimation of 
antibody-producing cells (PFC's),  and radioautographic techniques have been described in 
TABLE I 
Acute Effecl of Aclinomycin D on PFC's In Vitro 
PFC/10~ spleen  cells, hr 
Actinomycin  D 
0  1.5  3.5  5.5  24 
~g/¢u/ture 
0  1009  968  582  481  995 
0.01  1009  704  507  575  1140 
10.0  1009  555  236  145  146 
Spleen cell suspensions from a rabbit killed 3 days after a boost of SRC's were incubated 
at 10  7 cells/culture containing 5 X  10  6 SRC's in the presence or absence of actinomycin D. 
The numbers of PFC's were assayed at the times shown. The volume of medium used for 
individual cultures in this and all subsequent experiments was 1.5 ml. 
detail  (23, 1). Actinomycin D was a generous gift from Merck, Sharp and Dohme, Rahway, 
N. J., and puromycin was purchased from Nutritional  Biochemicals Corporation, Cleveland, 
Ohio. Both antibiotics were stored under refrigeration in the dark  and either made up in 
solution immediately before use or used within 3 wk of preparation. 
IsotopicallyLabded  Matzr/a/s--Thymidine-14C at 30.4 mc/m~r; thymidine-3H at 2.16 c/ 
mM, used at 300 mc/m~,; uridineA4C  at 32 me/m~,; uridine-aH at 2.18 c/ram; leucine-14C  at 
32 mc/m~,; and leucine-SH at 18.3 c/nm were obtained  from the Radioehemical Centre, 
Amersham, England.  Methods  of measurement of uptake of 3H-labeled (24, 25)  and 14C- 
labeled materials (23) have been fully described. 14C-labeled  precursors were used for radio- 
autography  of PFC's by the methods detailed elsewhere (1). 
RESULTS 
The acute effect of actinomycin D  on PFC's is seen in Table I. Low concen- 
trations of the inhibitor  in the medium had no appreciable effect on the numbers 
of PFC's from the spleen of a rabbit killed 2 days after an intravenous boost of 
SRC's, while a high concentration depressed the numbers of PFC's after 3 hr 
incubation. The results of a typical experiment shown in Table II indicate that QmMO~mRRm  677 
the rate of RNA synthesis,  measured by the incorporation of uridine-SH, was 
inhibited after 30 rain incubation of rabbit spleen cells with a high concentration 
of actinomycin D. Assay of PFC's in identical cultures showed that antibody 
production was not affected until after several hours exposure to the inhibitor, 
maximal reduction of PFC's requiring  6 hr of contact with actinomycin D. 
The long-term effects of high concentrations of actinomycin D on PFC's in 
spleen cell suspension from boosted rabbits are shown in Table IH. Spleen ceils 
from rabbits killed  3 or  2 days after boosting with SRC's were  exposed  to 
actinomycin  D, added to cultures initially. After a marked suppression of PFC's 
TABLE II 
The Acute Effect of Actinomycin D on PFC's and RNA Synthesis In Vitro 
Time 
0 
0.5 
1 
2 
3 
4 
6 
12 
24 
SRC 
2750 
2640 
2590 
2260 
2020 
1830 
1150 
1420 
403 
PFC/IOe spleen cells 
SRC +  Act.D  SRC + 
Act.D  SRC  X 100 
2750  100.0 
2651  100.5 
2349  90.8 
2412  106.0 
1365  67.5 
1080  60.0 
28  2.4 
49  3.4 
20  4.9 
RNA synthesis, uridine-tH uptake 
SRC -[- Act.D 
SRC +  SRC  SRC  Act.D  X 100 
cpm/t~lt~t 
72,772  12,509 
74,503  10,990 
76,068  16,803 
75,059  7,582 
66,914  2,995 
99,410  1,896 
98,030  1,802 
107,220  2,185 
17.3 
13.4 
i  22.0 
i  10.1 
i  4.5 
i  1.9 
1.8 
2.0 
Spleen cell suspensions from a  rabbit killed 2 days after a  boost injection of SRC's were 
incubated with 5  X  106 SRC's/culture (SRC)  or in the presence of actinomycin D  10/~g/ 
culture as well as SRC's (SRC +  Act.D). The numbers of PFC's and the  incorporation of 
uridine-3H, 2 ~tc/culture, which was added initially, were estimated at the times indicated. 
during the first 2 days of culture, a recovery of the ability of the cell suspensions 
to produce PFC's was seen. The recovery of numbers of PFC's was always best 
in cultures of spleen cells from rabbits killed 3 days after boosting,  and in- 
creases well above the numbers of PFC's in cultures which had never been ex- 
posed to actinomycin D frequently occurred. In many experiments with spleen 
cells from rabbits boosted 2  days before killlug,  any recovery of hemolytic 
plaque-forming ability by cells, after initial suppression by actinomycin D, was 
much lower than with cells from rabbits boosted 3 days before. As seen in Table 
III, no recovery might be seen in suspensions of spleen cells from rabbits killed 
after a boost 2 days before, but PFC's were never completely suppressed  by 
high concentrations of actinomycin D. Experimental results,  not shown here, 
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killing and incubated with actinomycin D, but in the absence of specific antigen 
in the medium, showed little or no recovery of PFC's in vitro. Therefore,  the 
presence of specific antigen in the culture medium was necessary for this ap- 
parent stimulatory effect of high concentrations of actinomycin D  on PFC's, 
after  initial  suppression.  Spleen  cells  from  nonboosted  and  nonimmunized 
rabbits were never stimulated by actinomycin D  in this way. 
TABLE III 
The Long-Term Effect of Actinomydn  D In Vitro 
Experiment 
159 
162 
163 
7659 
7504 
boost  myon  D 
t~g/culture 
0 
20 
0 
10 
0 
0.01 
10.0 
0 
10 
0 
20 
0 
11,900 
11,900 
682 
682 
1,009 
1,009 
1,009 
11 
710 
4,900 
4,900 
PFC/10e spleen cells, days 
1233 
75 
1020 
31 
995 
1140 
146 
690 
47 
2140 
33 
1193 
174 
786 
16 
217 
970 
160 
710 
38 
1020 
200 
1146 
229 
m 
10 
49 
321 
331 
350 
6 
130 
2 
4 
1515 
339 
699 
1200 
38 
450 
22 
7 
48 
11 
5  6 
199  -- 
85  -- 
14  21 
5  3 
57  13 
2  4 
156 
71 
169 
420 
7  8 
108 
64 
91 
24 
34 
450 
15 
3 
Spleen cell suspensions from rabbits killed either 2 days or 3 days after a boost injection 
of SRC's were cultured in the presence  of 5  X  106 SRC/culture and actinomycin D  was 
added initially.  The number of PFC's was estimated dally, and was calculated as the propor- 
tion of ceils initially set up in cultures in this and all subsequent tables. 
In view of this interesting and unexpected observation, further experiments 
involving the addition of acfinomycin D  to suspensions of rabbit spleen cells at 
different times were carried out.  Removal of actinomycin D  from cultures by 
washing the cells three times in medium and then reincubating in inhibitor-free 
medium did not show any reversal of the effects of the antibiotic after it had 
been in contact with the cells for at least 4 hr. When more actinomycin D  was 
added to cells which had been exposed initially to the antibiotic and after re- 
covery of the numbers of PFC's had occurred, no further inhibition of PFC's 
was seen. 
The results in Table IV show the typical effect of adding a high concentration 
of actinomycin D  to spleen cell suspensions from a  rabbit killed 2 days after a GI_LMOUR HARRIS  679 
boost of SRC's. When added initially, the actinomycin D  inhibited the PFC's 
in cultures incubated in the presence or absence of SRC's, but a  small number 
of active PFC's persisted in both types of cultures. Addition of actinomycin D 
on various days of culture, in the same concentration as suppressed PFC's when 
added to cultures initially, progressively stimulated an increase in the number of 
TABLE IV 
The Effect on PFC's of Adding Adinomycin D at Different  Times in Culture 
Cultures 
PFC/IO  e spleen cells, days 
0  1  2  3  4  5  8 
Controls  (C)  823  414  51  40  64  19  8 
SRC  .....  --  1010  410  101  167  45  12 
Act.D on day 0 
Act.D on day 1 
Act.D on day 2 
Act.D on day 3 
Act.D on day 4 
Act.D on day 7 
C 
SRC 
C 
SRC 
C 
SRC 
C 
SRC 
C 
SRC 
C 
SRC 
5  9  --  21  16  38 
11  6  --  26  9  28 
15 
65 
37 
610 
52 
4120 
29 
145 
15 
135 
Spleen cell suspensions from a rabbit killed 2 days after a boost injection of SRC's were 
incubated in the absence (C) or presence (SRC) of the antigen. Actinomycin D, 10/~g/culture, 
was added at the times shown and the numbers of PFC's estimated on the days of culture 
indicated. 
PFC's  only in  spleen  cell suspensions  incubated  with  SRC's.  The  maximal 
stimulation was seen on day 4 of culture when actinomycin D  had been added 
on day 3.  Although no enhancement  of PFC's was seen in cultures incubated 
without SRC's, the surviving antibody-producing cells were resistant to actino- 
mycin D. While these results were completely typical, other similar experiments 
showed some variation of the time of addition of actinomycin D  which produced 
maximal  enhancement  of PFC's,  this  time varying from  day  2  to  day 4  of 
culture. The stimulating effect on PFC's of actinomycin D  added to cultures in 680  ANTIBODY  PRODUCTION  IN  VITRO.  II 
this way always increased the number of antibody-producing cells above the 
levels found  in  cultures  incubated  in  the presence  of  SRC's  alone.  Another 
variable feature was the time in culture, after adding actinomycin D, that en- 
hancement of PFC's persisted. In some experiments, as shown in Table V, in- 
crease  of PFC's  was maintained in this way for several days while, in others, 
there was a rapid fall in the number of PFC's 24-48 hr after the initial increase. 
TABLE V 
The Maintenance of the Stimulating Effect of Actinomycin D  on PFC's In Vitro 
Cultures 
C 
SRC 
SRC +  Act.D 
Day 3 
Day 4 
0 
96OO 
PFC/IO  6 spleen cells, days 
1 
2330 
2720 
4 
2 
231 
485 
10 
3  4 
42  25 
110  67 
41  1204 
--  1507 
68 
136 
1100 
1440 
2096 
7 
27 
1010 
2410 
1340 
70 
65 
1500 
2790 
1690 
Spleen cell suspensions from a rabbit killed 3 days after a boost of SRC's were incubated 
in medium alone ((2) or with 5 X  106 SRC's/culture (SRC). Actinomycin D, 10 gg/culture, 
was added initially (SRC  +  Act.D) or on day 3 or day 4 to cultures exposed initially to 
SRC's and the number of PFC's estimated daily. 
TABLE VI 
The Effect on PFC's of Actinom 
Actinomycin D 
gg/culture 
0 
0.1 
1.0 
I0.0 
100.0 
,dn D Added on Day 3 of Culture 
PFC/10 6 spleen cells  (day 4) 
167 
970 
1880 
4120 
3530 
Actinomycin D was added on day 3 of culture to spleen cell suspensions from  a rabbit 
killed 2 days after a boost injection of SRC's. The number of PFC's were counted 24 hr after 
adding the actinomycin D to the cultures, which were incubated with SRC's, added initially. 
The optimal concentration  of actinomycin D  which stimulated the appear- 
ance of specific PFC's in vitro was much higher than the level of the antibiotic 
required, in cultures of spleen cells from recently killed rabbits, to inhibit DNA, 
RNA, and protein synthesis. As shown in Table VI, a concentration of 100 ~g/ 
culture was still highly sdmulatory.  In addition, the results in Table VII in- 
dicate that the response of PFC's to actinomycin D, enhancing their numbers, 
was time-dependent, reaching a  maximal level after 4 hr exposfire to the antibi- 
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The effect of actinomycin D  on the incorporation of thymidine,  uridine, and 
leucine was studied in spleen cell suspensions from immunized rabbits. As shown 
in Table VIH, actinomycin D  inhibited incorporation of thymidine and uridine 
when added initially to cultures,  uridine uptake being depressed much earlier 
and to a  greater degree than  the incorporation of thymidine. 
TABLE VII 
The Effect on PFC's at Different  Times of the Addition of Aainomycin D to Cultures on Day 3 
Actinomycin D 
10 ~&/culture 
SRC 
SRC +  Act.D 
167 
150 
PFC/IO  s  spleen  cells,  kr 
4  5 
410  150 
24 
45 
145 
Spleen cell suspensions from a rabbit killed 2 days after a boost of SRC's were cultured in 
the presence of 5 X  10  s SRC/culture.  Actinomycin D, at 10/~g/culture,  was added  (SRC -I- 
Act.D) on day 3, and the numbers of PFC's were estimated at the times shown. 
TABLE VIII 
TheAc~eEff~t~  Aa~omyc~ D  ~  DNA  a~RNA  Synlh~ 
Rate of DNA synthesis (thymidlne uptake,  Rate of RNA synthesis (uridine uptake, 
cpm/culture) per cent of controls  cpm/culture) per cent of controls 
Aetinomycin D 
~g/cultum 
0.01 
1.0 
o-lh_____i_r 1-2h----Z--' 
100  I  100  86  100 
I  1°°1  741  a9  I  al 
0-1 hr  1-2 hr  2-3 hr  3-4 hr 
100  I  sa.°  [  Sl.°  [  67.0 
27  I  1"71  15  [  08 
Spleen cell suspensions from a rabbit boosted with antigen 2 days before killing were incu- 
bated in actinomycin D as shown. The uptakes  of thymidine-3H and uridine-SH, both at 2 
/zc/culture, were estimated for 1 hr periods between 0 and 4 hr of incubation, and the amounts 
incorporated were calculated as per cent of identical control cultures, incubated without any 
actinomycin D. 
The experiment reported in Table IX indicates that the addition of actino- 
mycin D  to cultures initially inhibited the rate of DNA synthesis, as measured 
by the incorporation of thymidine,  during the  24-48 hr period of culture.  In 
this period, maximal differences were seen between control cultures incubated 
in medium alone and identical cultures incubated in the presence of a stimulant 
to cell proliferation, such as the specific antigen or phytohemagglutinin (PHA). 
Spleen ceils which were responding to antigen or PHA appeared more sensitive 
to the inhibitory effect of actinomycin D  on thymidine incorporation than did 
control cells. 
Actinomycin D  had a  profoundly depressive effect on uridine incorporation 682  ANTIBODY PRODUCTION IN  VITRO. II 
during the first 24 hr period of culture of rabbit spleen cell suspensions when the 
rate of RNA synthesis was most active (Table X). Incorporation of uridine was 
never completely suppressed by actinomycin D  during this period of culture. 
As seen in these results,  incorporation of  uridine fell to low  levels after this 
initial active period, even in cultures not exposed to inhibition, and this can be 
TABLE IX 
The Long-Term Effects of Actinomycin  D In Vitro on Thyraidine Uptake 
Actlnomycin D 
~g/culture 
0 (control) 
0.001 
0.01 
0.1 
1.0 
Rate of DNA  synthesis,  24--48  hr  (thymidine uptake) 
cpm/culture 
786 
745 
373 
60 
110 
Per cent of 
control 
100 
95 
47 
8 
14 
SRC 
cpm/culture  Per cent of 
SRC control 
2560  100 
1010  39 
360  14 
20  0.8 
20  0.8 
PHA 
cpm/culture  Per cent of 
PHA control 
6120  100.0 
433  7.0 
170  2.8 
100  1.5 
83  1.1 
Spleen  cell  suspensions  from a rabbit  killed  2 days  after  a boost  of  SRC's were  incubated 
in  medium alone  (C),  SRC's  at  5 X  106/culture  SRC, or  Bacto-phytohemagglutinin P (PHA, 
Difco  Laboratories,  Inc.,  Detroit,  Mich.) at 10  #g/culture.  Different  concentrations  of  acti- 
nomycin D  were added initially  and thymidine-14C  uptake, 0.2 jzc/culture  was estimated 
during  24-48  hr  of  incubation  and calculated  as  the  per  cent  of  identical  cultures,  incubated 
without actinomycin D. 
TABLE X 
The Long-Term Effects of  Actinomycin D In Vitro Uridine-Stt Uptake; the Effects of Removal 
or Delay in Addition of Actinomycin  D 
Cultures 
C 
SRC 
C 
SRC 
C 
SRC 
Actinomycin  D 
(10 ~,g/culture) 
day added 
1 
1 
3 
3 
Rate of RNA synthesis (uridine uptake, 12 hr pulse, cpm/culture), 
days 
1-2  3-4 
12,829 
12,566 
564 
520 
4--5  5-6 
132  2785 
526  3152 
125  1305 
854  1352 
796  836 
775  744 
161,243 
272,636 
670 
619 
6-7 
1705 
831 
1349 
748 
632 
763 
Spleen cell suspensions from a boosted rabbit were incubated in medium alone (C) with 
5 X  106 SRC's/culture (SRC). Actinomyein D was added initially to cultures as indicated. 
All cultures were washed by centrifugation two times in medium on day 2 of culture, and incu- 
bation was continued in inhibitor-free medium, no further antigen being added. GILMOIm H.tm~m  683 
correlated with increased cell death and fewer cells labeled on radioautography 
(personal observations).  The significance of this low level of incorporation re- 
quires  further study by more detailed methods since  the  amount of labeled 
precursor incorporated by cells in noninhibited cultures was virtually the same 
as in cultures exposed to actinomycin D  which had been added initially. When 
actinomycin D  was added on day 3 of culture, for the first time, no further in- 
hibition of these low levels of incorporation of uridine was seen. 
The results of a typical experiment to show the effect of a high concentration 
of actinomycin D  on the incorporation of leucine-aH by spleen from immunized 
TABLE XI 
The Long-Term  Effects of Aainomydn D In Vitro on Leudne Incorporation 
Protein synthesis (leucine uptake, c pm/culture), days 
Cultures  0  1  2  3  4  1  2  3  4 
1 hr pulses  24 hr pulses 
C 
HSA 
HSA +  Act.D 
HSA +  Act.D on 
day 3 
12,662  1858  2134  815  759  101,499  36,748 26,991  7,117 
102,481  41,738 38,193 12,622 
8,809  62  96  472 
12,662 
12,662 
2929  3789 
75  121 
1514 
2O3 
635 
207 
201 
Spleen cell suspensions from a rabbit boosted 2 days before killing, with human serum al- 
bumin (HSA) obtained as a gift from the Lister Institute of Preventive Medicine, London, 
were incubated in medium alone (C) or with antigen at 1 mg/culture (HSA). Actinomycin D 
was added initially at 10 #g/culture  (HSA -4- Act.D) or on day 3 of culture at the same con- 
centration. Cultures were washed, and incubation was continued in leucine-free medium to 
measure the uptake of leucine-SH, 5 btg/culture, for 1 hr and 24 hr pulses, on the days of 
ctflture indicated. 
rabbits are shown in Table XI. Like the incorporation of uridine-3H, leucine-3H 
uptake was initially high in these cultures and was depressed by actinomycin D 
in high concentration, but inhibition was never completely achieved, even with 
doses higher than were used here. Leucine-3H uptake fell rapidly to low levels 
with time in culture and this fall of incorporation of leucine-~H was related to 
cell death and fall in numbers of labeled cells on radioautography (personal ob- 
servations).  When actinomycin D  was added to cultures on day 3, there was 
still some inhibition of leucine uptake but this was not completely suppressed. 
Similar experiments have been carried out using puromycin to inhibit leucine 
incorporation in these rabbit spleen cell suspensions. Preliminary observations 
showed that puromycin at 50 #g/culture  achieved maximum inhibition.  The 
results of Table XII correlated the effects of this concentration of puromycin on 
leucine incorporation and the number of PFC's in spleen cell suspensions from a 684  ANTIBODY  PRODUCTION  IN  VITRO.  II 
TABLE  XII 
The Acute Effect of Puromycin In Vitro 
Time 
]$r 
0 
1 
2 
3 
4 
24 
Protein synthesis (leuclne, uptake, 
cpm/culture)  PFC/10 s spleen  cells 
Puromycin, ~g/culture 
0  50  0  50 
37,516 
29,147 
37,253 
18,619 
(--)* 
14,800  (39) 
5,598  (19) 
5,062  (16) 
1,438  (7.7) 
4250 
3450 
1660 
4025 
875 
985 
--  (--) 
55  (1.6) 
45  (2.7) 
20  (o.5) 
20  (2.2) 
37  (3.7) 
* Nos. in parentheses represent per cent of controls. 
Spleen cell suspensions from a  rabbit boosted with SRC's 3 days before k~l]~ng were incu- 
bated in the presence of puromycin, 50 #g/culture. The incorporation of leucine-SH, 5 #c/cul- 
ture, was measured for 1 hr periods during the first 4 hr of culture and  the numbers of PFC's 
estimated at the times shown. Results were calculated as per  cent of similar control cultures 
incubated without puromycin. 
TABLE  XIII 
The Effect of Inhibitors  on Individual  PFC's 
Inhibitor 
t~g/culture 
Actinomycin D 
0 
10 
10 
Actinomycin D 
0 
10 
10 
Puromycin 
0 
50 
50 
Day added 
2 
3 
m 
2 
3 
2 
3 
Spleen ceils from a  rabbit killed 
PFC/106 spleen cells, days 
0  3  4 
3650  450  330 
--  950  1321 
--  --  750 
3650  450  330 
--  950  1321 
--  --  750 
3650  450  330 
--  970  860 
--  --  1270 
Labeled PFC's, days 
0  3  4 
%  %  % 
Uridine-14C 
100  35  i  0.2 
--  0  0 
--  --  0 
I 
I 
Leucine-uC 
100  53  1 
--  2.8  2.9 
--  --  [  2  l 
i 
Leucine-14C 
100  53  1 
--  0  0 
--  --  I  1 
days after a  boost injection of SRC's were incubated in 
the presence of 5  X  106 SRC's/culture and actinomycin D  or puromycin were added to cul- 
tures in the concentrations and at the times shown. The cultures were incubated in uridine-x4C, 
0.5 #c/culture or leucine-14C, 0.5 #c/culture for 4 hrs before plating, and the number of PFC's 
and per cent of labeled PFC's estimated by radioautography of the antibody-producing cells. O~OtrR HARRIS  685 
rabbit killed 3 days after a boost of SRC's. In contrast to the effects of actino- 
mycin D, there was a prompt, profound inhibition of leucine uptake as well as 
reduction in the number of PFC's which was sustained over a period of 24 hr. 
It has been shown (1) that, in spleen cell suspensions from rabbits undergoing 
a secondary response to SRC's only a small proportion of cells responding  to 
antigen in vitro by an enhanced rate of DNA synthesis and cell division actually 
became PFC's, and that they accounted for virtually all the PFC's developing 
in these cultures.  It was therefore important to attempt direct observation on 
the individual cell releasing  antibodies  to the SRC's.  Results of experiments 
which  have  correlated  the effects of actinomycin D  and puromycin on  the 
number of PFC's with radioautography of these cells are shown in Table XIII. 
The incorporation of both urldine-14C and leucine-14C into individual PFC's 
falls with time in culture in the presence  of SRC's but in the absence of in- 
hibitors.  Actinomycin D, added on day 2 or day 3 of culture, enhanced the 
number of PFC's but  completely inhibited the incorporation of uridine-l*C 
into individual PFC's. While a few cells appeared to be labeled with leucine-14C 
after contact with actinomycin D, the degree of labeling was very light com- 
pared with slmilar  cells not exposed to the antibiotic.  The majority of  cells 
showed no label above background in these preparations.  Puromycin produced 
very similar effects to actinomycin  D, with marked enhancement of the number 
of PFC's compared to cultures not exposed to the antibiotic.  In the same way, 
the vast majority of these PFC's did not show any evidence of labeling with 
leucine-14C on radioantography. 
DISCUSSION 
Acute Effects of Inhibitors.--Actinomycin  D, added to spleen cell suspensions 
immediately after isolation from rabbits killed after boosting with SRC's, pro- 
duced marked suppression of the numbers of PFC's. This inhibition of antibody- 
producing ceils by high doses of actinomycin D only occurred after suppression 
of RNA synthesis as measured by the incorporation of uridine-SH had been 
achieved. This agent has been shown to have a highly selective action, inhibiting 
DNA-dependent RNA synthesis (2). Low doses of actinomycin D in vitro have 
been found to inhibit nucleolar RNA synthesis but to permit continued syn- 
thesis of RNA with a DNA-like base composition  (3), while high doses of 1-5 
/zg/ml in cultures have been shown to inhibit 95 % of total RNA synthesis in 
animal cells (26). High concentrations of actinomycin  D were used in the present 
experiments and, while the exact nature of the RNA's suppressed in the mixed 
populations present in rabbit spleen cell suspensions would be difficult to evalu- 
ate, total RNA synthesis was profoundly depressed by this agent. If antibody 
synthesis in these cultures was dependent on messenger RNA, and if inhibition 
of messenger RNA were responsible for cessation of antibody synthesis (5), it 
would appear that this template RNA, in antibody-forming cells from spleen 
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lapse of about 2 hr between suppression of uridine incorporation by actinomycin 
D  and reduction in numbers of PFC's. This conclusion would agree with the 
results of studies (6) using the incorporation of labeled amino acids into anti- 
body protein by lymph node cells from immunized rabbits, and further indicates 
that  specific  hemolytic plaque formation by recently isolated  ceUs from  the 
spleens  of rabbits, killed  after a boost of SRC's, was dependent on the normal 
processes of protein synthesis. The acute effects of inhibitory concentrations of 
puromycin on such cells would confirm this.  This antibiotic suppresses protein 
synthesis (18-22), and in the present experiments inhibition of PFC's in recently 
isolated spleen cell suspensions  from boosted rabbits could be correlated with 
the inhibition of the incorporation  of leucine-~I-I  by all the cells  in these sus- 
pensions. 
Long-Term Effects of Inhibitors.--The  long-term effects  of actinomycin D and 
puromycin in vitro on the number of PFC's present in suspensions of spleen 
ceils from rabbits killed 3 days after boosting with SRC's was unexpected. The 
presence of SRC's in  the  culture medium was essential for recovery in  the 
number  of PFC's  to occur after inhibition  by actinomycin D  or puromycin 
added initially to the cultures. This recovery pattern was typically greater and 
more constant in  suspensions  of spleen cells taken from rabbits 3 days after 
boosting with antigen than in similar  suspensions  from rabbits boosted 2 days 
before killing  These observations indicate that  there  were differences  in the 
populations of antibody-producing ceils in the spleens  from rabbits boosted 3 
days before killing  compared  to similar populations from animals  boosted 2 
days before killing. The results presented here show that high concentrations of 
actinomycin D could rapidly suppress both RNA and DNA synthesis rates when 
added initially to these spleen cell suspensions and that this effect was sustained; 
but the presence of antigen, added initially to the cultures, was still able to in- 
duce the appearance of PFC's by day 3 of culture despite the presence of the 
inhibitor. (It should be noted that an exactly similar recovery of PFC's exposed 
to puromycin, added initially to cultures, also occurred). The intravenous in- 
jection of SRC's into the rabbits before killing  them for these experiments had 
already triggered a proliferative responsive population of ceils in their spleens. 
It has been shown (23) that many of the dividing cells can be stimulated to 
further  divison by antigen  in vitro, and  that  the PFC's which developed in 
vitro were derived from this population of DNA-synthesizing ceils (1).  If all 
messenger RNA synthesis was interrupted by actinomycin D, added initially 
to these cultures, and if hemolytic-plaque formation was still dependent on pro- 
tein synthesis continuing in the presence of this agent, then the existence of a 
highly stable messenger RNA necessary for the synthesis of the antibody mole- 
cule must be postulated. A more remote possibility would be that  the produc- 
tion of messenger RNA for specific antibody synthesis continued in the presence of 
inhibitor. Another point to be considered was whether ceils present in the spleens oiLMom~ HARriS  687 
of rabbits killed 3 days after boosting had already been induced to prepare for 
specific antibody synthesis before  exposure  to antigen in vitro. Since actino- 
mycin D, in  high concentration, completely prevented  the proliferative re- 
sponse of cells to antigen in vitro, and since it has been shown (1) that this re- 
sponse was necessary for the maintenance of PFC's in vitro, antigen must be 
acting, in some way, on cells which had been committed in vivo to synthesize 
specific antibody even though they were under the inhibitory effects of actino- 
mycin D. If the PFC's present in rabbit spleen cell suspensions 3 days after 
exposure, in vitro, to high concentrations of actinomycin D or puromycin were 
the result of an in vitro response to antigen requiring DNA and RNA synthesis 
by PFC's, then antigen would have had to act very quickly before inhibition by 
these agents had occurred.  This is unlikely since the proliferative response of 
cells to antigen added initially, in these cultures, was never seen until long after 
maximum suppression by these inhibitors would have occurred. Other experi- 
ments, not reported here, have shown that when actinomycin D or puromycin 
was added initially to cultures several hours before antigen, which was added 
after maximum suppression by these inhibitors had been achieved, recovery of 
PFC's still occurred by d~ys 3-4 of culture. 
The Effect of Delay in Addition of Inhibitors to Cultures.--When actinomycin 
D or puromycin was added to suspensions of spleen cells from boosted rabbits 
at various times in culture, not only was there an increasing resistance  of the 
surviving PFC's in control cultures,  incubated without SRC's, but increases in 
the numbers of PFC's occurred  only in cultures incubated with SRC's. This 
stimulating effect was only seen in spleen cell suspensions from rabbits boosted 
with SRC's and was never found with nonhoosted and nonlmmunized controls, 
or with rabbits immunized to other antigens.  High concentrations of the in- 
hibitors were required for this stimulating effect which was best seen after 48 
hr exposure to antigen in vitro. PFC's in spleen cell suspensions from rabbits, 
boosted 2 days before killing, were stimulated in this way in contrast to the lack 
of stimulation in many such cultures by inhibitors added initially. These results 
suggest that the PFC's, releasing specific antibody in the presence of actinomy- 
cin D or puromycin added after an adequate period of contact with antigen, had 
developed,  in response  to antigen in vitro, as the result of proliferation and 
differentiation  into antibody-synthesizing  cells (PFC's). When the time required 
for high concentrations of actinomycin D to produce an increase of PFC's was 
studied, it was found that this corresponded  very well to the time taken for 
suppression  of PFC's by actinomycin D  added, in the same concentration, to 
freshly isolated ceils from the spleens of boosted rabbits. If both actinomycin D 
and puromycin were simply acting as nonspecific toxic agents to injure cells so 
that they passively released  antibody during the plating procedure  used to 
assay PFC's, it would be most unlikely that the level of PFC's would be sus- 
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patterns of depression and recovery in numbers of PFC's seen in cultures ex- 
posed initially to these agents. In addition, it would be difficult to understand 
how the presence of antigen in vitro could affect dead or such severely injured 
cells.  It is therefore concluded that these results demonstrated some form of 
stimulation of  antibody-producing cells  as  the  result  of  the  effects of these 
inhibitors. Another point to be considered is that these PFC's were inhibited by 
exposure to high concentrations of oxygen during plating (1),  suggesting that 
plaque-forming ability required active processes for release of antibody. 
Effect  of InMbitors  on  Incorporation  of Precursors.--Incorporation  of  pre- 
cursors to measure the synthesis rates of DNA,  RNA, and  protein  by  these 
spleen cell suspensions indicated that marked inhibition resulted from the action 
of these inhibitors added initially. The most detailed results presented here show 
that actinomycin D, added initially in high concentration, was an effective in- 
hibitor of all synthetic functions. The incorporation rates of precursors fell to 
low levels after 2 days in vitro even in the absence of inhibitors in the culture 
medium. This was associated with reduction in the proportions of labeled ceils 
on radioautography to virtually zero levels by day 4 of culture and by increas- 
ing cell death as shown by staining of > 95 % of cells with trypan blue at this 
time (personal observations). Therefore, these results must be interpreted with 
some caution in view of marked changes in precursor pools which would have 
occurred with time in culture. However, in other experiments, increases of the 
amounts of labeled precursors added to the cultures, as well as changing the 
culture medium,  did not significantly alter  the  incorporation rates  of these 
precursors. More detailed studies will be required to establish the significance 
of the low level of labeled materials incorporated into the TCA-precipitable 
cell material at this time. If incorporation of precursors, measured after day 3 
in vitro,  indicated true synthesis of  RNA  and protein,  then these processes 
would appear to be highly resistant to the effect of actinomycin D in high con- 
centration. 
Radioautography of PFC's.--In view of these problems, and the fact that only 
a  small proportion of cells  were PFC's in these cultures, radioautography of 
individual cells forming hemolytic plaques after incubation with leucine-14C or 
uridine-l*C  was carried out. The results show that the vast majority of PFC's 
producing antibody in the presence of actinomycin D  or puromycin were not 
labeling with uridine-14C or leucineJ4C in the ease of the former inhibitor, or 
with leucine-14C in the case of the latter, indicating that plaque formation in 
these cells was not dependent on the normal processes of protein synthesis as 
had been observed in PFC's from the spleens of recently killed rabbits during 
the first 24 hr in vitro. In addition, it was found that PFC's surviving in cultures 
of spleen cells from boosted rabbits not exposed to inhibitors, showed a progres- 
sive fall, with time in culture, of the numbers of PFC's labeling with uridine- 
t4C or leucine-14C. Since these results indicate that the antibody released by 
PFC's in the presence of actinomycin D  and puromycin might be preformed it oiLuo~ nnm~s  689 
would be of interest to investigate whether these ceils contained complete anti- 
body molecules in an intracellular pool or possessed completed light and heavy 
chains which had not yet been assembled into whole molecules before exposure 
to inhibitors.  If the antibody molecules were completed,  they must have been 
released from the ribosomes on which the polypeptide chains had been synthe- 
sized since evidence with IgG molecules (27) and hemoglobin molecules  (28) 
has suggested that polypeptide chains are synthesized on different polysomes. 
Puromycin has been shown to produce release of incomplete polypeptide chains 
from the isolated ribosomes of rabbit reticulocytes (29, 30) and it was therefore 
a possibility that puromycin, in the present experiments, could promote release 
of light chains from the ribosomes of potential PFC's which could in turn con- 
trol the release of heavy chains from their separate polysomes, as has been sug- 
gested in studies of an ascitic form of murine plasmacytoma (31) and hemoglo- 
bin synthesis (28). This possibility will require further exploration by studies of 
preparation of ribosomes from rabbit spleen cells after culture in vitro. 
Although no definite statement can be made at present, results  of exposing 
spleen cells from boosted rabbits to both inhibitors simultaneously  in vitro show 
a lack of summative effects on the number of PFC's, thus suggesting that the 
same cells were affected by these inhibitors.  This would indicate some common 
mode of response by PFC's in these cultures to two agents with differing modes 
of action. It would be possible to invoke an inhibitory effect by a repressor gene 
whose product would depend on both RNA and protein synthesis for its syn- 
thesis. A model such as the "blocked" ribosome (32) might be envisaged.  Thus 
inhibition of the synthesis of the product of the repressor gene by actinomycin 
D or puromycin would allow translation to be completed. Under these circum- 
stances antigen, or its product, might be acting as an inducer, aiding release of 
the polypeptide chains. 
SU~rCrAI~Y 
The effects of actinomycin D and puromycin on spleen cell suspensions from 
rabbits jrnrmmized to SRC's were studied. These inhibitors,  in high concentra- 
tion, suppressed  PFC's when added initially to recently isolated cells. When 
such cells were incubated for several days in the presence of both antigen and 
inhibitor,  both actinomycin D and puromycin produced an increase in PFC's 
after the initial suppression. This recovery effect was best seen with cells from 
rabbits killed 3 days after boosting with SRC's, and was usually absent when 
cells were taken from rabbits killed 2 days after boosting. When actinomycin D 
or puromycin was added after several days in culture in the presence of SRC's, 
surviving PFC's were found to be not only resistant to these inhibitors,  but 
there was also an increased number of PFC's compared to similar cultures in- 
cubated without these agents. 
Radioautographic studies showed that PFC's stimulated by the presence of 
actinomycin D  or puromycin were not incorporating precursors  for RNA or 690  ANTIBODY PRODUCTION IN VITRO. II 
protein synthesis. In view of the known mode of action of these inhibitors, it was 
postulated that they were stimulating antibody production by PFC's in vitro 
either by interfering with represser mechanisms or stimulating the completion 
of antibody molecules, perhaps by causing the release of preformed antibody 
chains from ribosomes. 
Since the presence of specific antigens in vitro were necessary for these ob- 
served  stimulatory  effects on  PFC's,  and  since  antigens  were  producing  an 
effect on antibody production on cells which were being suppressed by these 
inhibitors,  added initially, it was further suggested that one role of antigen in 
the immune response was concemea with the completion of antibody synthesis 
on the ribosomes, perhaps by acting as an inducer as has been suggested pre- 
viously (1). 
I wish to thank Professor P. G. H. Gell for critical discussion, and Miss J. Lowe  and Mrs. 
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